RenovoRx, Inc.
RNXT
$0.87
$0.022.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -36.97% | 114.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -36.97% | 114.21% | |||
| Cost of Revenue | -65.13% | 61.70% | |||
| Gross Profit | -21.11% | 162.14% | |||
| SG&A Expenses | 13.53% | -3.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.80% | -6.26% | |||
| Operating Income | -19.49% | 13.89% | |||
| Income Before Tax | -0.59% | -19.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.59% | -19.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.59% | -19.63% | |||
| EBIT | -19.49% | 13.89% | |||
| EBITDA | -19.52% | 13.90% | |||
| EPS Basic | -0.51% | -2.59% | |||
| Normalized Basic EPS | -0.40% | -2.70% | |||
| EPS Diluted | -0.51% | -2.59% | |||
| Normalized Diluted EPS | -0.40% | -2.70% | |||
| Average Basic Shares Outstanding | 0.19% | 16.50% | |||
| Average Diluted Shares Outstanding | 0.19% | 16.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||